×
About 8,635 results

ALLMedicine™ Viral Hepatitis Center

Research & Reviews  2,690 results

Screening Protocol for the Evaluation of Potential Research Subjects
https://clinicaltrials.gov/ct2/show/NCT01036971

Aug 5th, 2022 - This protocol describes the screening process used by the National Institute on Drug Abuse (NIDA IRP) to assess potential research participants' eligibility for entering protocols of the NIDA/IRP. Through its clinical research protocols, the IRP a...

Evaluation of Lipid Profile in Different Grades of Non-alcoholic Fatty Liver Disease Diagnosed by Ultrasound
https://clinicaltrials.gov/ct2/show/NCT05486429

Aug 5th, 2022 - Liver cells play a major role in the regulation of lipid metabolism. They are the principal location for lipoprotein and cholesterol synthesis. In healthy individuals an equilibrium is preserved between utilization, biosynthesis and transfer of li...

Phase II Trial of Disulfiram With Copper in Metastatic Breast Cancer
https://clinicaltrials.gov/ct2/show/NCT03323346

Aug 3rd, 2022 - Inclusion criteria: Patients with stage IV breast cancer with metastases demonstrated by appropriate imaging techniques Histologically or cytologically confirmed tumor Age of 18 years or more Eastern Cooperative Oncology Group (ECOG) performance s...

Clinical Performance of LIVERFASt Test Compared w/ Liver Biopsy in Patients w/ NAFLD.
https://clinicaltrials.gov/ct2/show/NCT04579874

Aug 2nd, 2022 - Chronic liver diseases (CLDs), such as chronic viral hepatitis, nonalcoholic fatty liver diseases (NAFLD) and nonalcoholic steatohepatitis (NASH), are a leading cause of morbidity and mortality globally and usually develops over many years. The pr...

Implementation of an integrated pharmacist collaborative care model in specialty diseas...
https://doi.org/10.1093/ajhp/zxac209
American Journal of Health-system Pharmacy : AJHP : Offic... Stroedecke N, Lee J et. al.

Aug 2nd, 2022 - In an effort to expedite the publication of articles, AJHP is posting manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and autho...

see more →

Guidelines  9 results

Cancer immunotherapy in special challenging populations: recommendations of the Advisor...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009216
Journal for Immunotherapy of Cancer; Gonzalez-Cao M, Puertolas T et. al.

Mar 31st, 2021 - Cancer immunotherapy based on the use of antibodies targeting the so-called checkpoint inhibitors, such as programmed cell death-1 receptor, its ligand, or CTLA-4, has shown durable clinical benefit and survival improvement in melanoma and other t...

EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris - Part 2: specifi...
https://doi.org/10.1111/jdv.16926
Journal of the European Academy of Dermatology and Venere... Nast A, Smith C et. al.

Feb 7th, 2021 - This evidence- and consensus-based guideline on the treatment of psoriasis vulgaris was developed following the EuroGuiDerm Guideline and Consensus Statement Development Manual. The second part of the guideline provides guidance for specific clini...

Joint Society statement for elimination of viral hepatitis.
https://doi.org/10.5604/16652681.1226808
Annals of Hepatology; Brahm J, Castera L et. al.

Jan 5th, 2017 - Joint Society statement for elimination of viral hepatitis.|2017|Brahm J,Castera L,Hou J,Lindor K,|standards,diagnosis,mortality,prevention & control,virology,standards,standards,standards,

ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries.
https://doi.org/10.1038/ajg.2016.517
The American Journal of Gastroenterology; Kwo PY, Cohen SM et. al.

Dec 21st, 2016 - Clinicians are required to assess abnormal liver chemistries on a daily basis. The most common liver chemistries ordered are serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase and bilirubin. These tests sh...

Who to test and how to test for chronic hepatitis C infection - 2016 WHO testing guidan...
https://doi.org/10.1016/j.jhep.2016.08.002
Journal of Hepatology; Easterbrook PJ,

Sep 20th, 2016 - Testing and diagnosis of hepatitis C virus (HCV) infection is the gateway for access to both treatment and prevention services, and crucial for an effective hepatitis epidemic response. In contrast to HIV, a systematic approach to hepatitis C test...

see more →

Drugs  4 results see all →

Clinicaltrials.gov  244 results

Screening Protocol for the Evaluation of Potential Research Subjects
https://clinicaltrials.gov/ct2/show/NCT01036971

Aug 5th, 2022 - This protocol describes the screening process used by the National Institute on Drug Abuse (NIDA IRP) to assess potential research participants' eligibility for entering protocols of the NIDA/IRP. Through its clinical research protocols, the IRP a...

Evaluation of Lipid Profile in Different Grades of Non-alcoholic Fatty Liver Disease Diagnosed by Ultrasound
https://clinicaltrials.gov/ct2/show/NCT05486429

Aug 5th, 2022 - Liver cells play a major role in the regulation of lipid metabolism. They are the principal location for lipoprotein and cholesterol synthesis. In healthy individuals an equilibrium is preserved between utilization, biosynthesis and transfer of li...

Phase II Trial of Disulfiram With Copper in Metastatic Breast Cancer
https://clinicaltrials.gov/ct2/show/NCT03323346

Aug 3rd, 2022 - Inclusion criteria: Patients with stage IV breast cancer with metastases demonstrated by appropriate imaging techniques Histologically or cytologically confirmed tumor Age of 18 years or more Eastern Cooperative Oncology Group (ECOG) performance s...

Clinical Performance of LIVERFASt Test Compared w/ Liver Biopsy in Patients w/ NAFLD.
https://clinicaltrials.gov/ct2/show/NCT04579874

Aug 2nd, 2022 - Chronic liver diseases (CLDs), such as chronic viral hepatitis, nonalcoholic fatty liver diseases (NAFLD) and nonalcoholic steatohepatitis (NASH), are a leading cause of morbidity and mortality globally and usually develops over many years. The pr...

Long-Term Study of Liver Disease in People With Hepatitis B and/or Hepatitis C With or Without HIV Infection
https://clinicaltrials.gov/ct2/show/NCT01350648

Jul 25th, 2022 - Chronic viral hepatitis is a major health problem affecting millions globally. The immunosuppressed population, especially those with HIV infection, remains at particular risk and the incidence of hepatocellular carcinoma (HCC) is increasing in th...

see more →

News  496 results

Gene Variants Found to Protect Against Liver Disease
https://www.medscape.com/viewarticle/978903

Aug 9th, 2022 - Rare gene variants are associated with a reduced risk for multiple types of liver disease, including cirrhosis, researchers say. People with certain variants in the gene CIDEB are one-third less likely to develop any sort of liver disease, accordi...

Statin use ties with lower HCC risk in dialysis patients with HBV or HCV monoinfection
https://www.mdedge.com/gihepnews/article/256537/hepatocellular-carcinoma/statin-use-ties-lower-hcc-risk-dialysis-patients

Jul 27th, 2022 - Key clinical point: Statin use is associated with a lower risk for hepatocellular carcinoma (HCC) incidence in dialysis patients with chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infection. Major finding: Statin users vs nonusers ha.

Bulevirtide Reduces Hepatitis D Viral Load in Difficult-to-Treat Patients
https://www.medscape.com/viewarticle/976608

Jul 6th, 2022 - Bulevirtide (Hepcludex) monotherapy significantly reduces the load of hepatitis delta virus (HDV) and is safe in difficult-to-treat patients with compensated cirrhosis and clinically significant portal hypertension, according to the results of an ...

Bulevirtide Beneficial in Hepatitis D: Phase 3 Data
https://www.medscape.com/viewarticle/976612

Jul 6th, 2022 - LONDON — Bulevirtide may not just treat but perhaps be a potential cure for hepatitis D in some patients, as was suggested at the annual International Liver Congress. Data from an ongoing phase 3 trial showed that, after 48 weeks of treatment, alm...

Finding HBV ‘cure’ may mean going ‘back to the drawing board’
https://www.mdedge.com/internalmedicine/article/256027/hepatology/finding-hbv-cure-may-mean-going-back-drawing-board
Sara Freeman

Jul 5th, 2022 - LONDON – Achieving a functional cure for hepatitis B virus (HBV) is not going to be easily achieved with the drugs that are currently in development, according to a presentation at the annual International Liver Congress sponsored by the European.

see more →

Patient Education  11 results see all →